It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DRTS’s FA Score shows that 0 FA rating(s) are green whileHOOK’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DRTS’s TA Score shows that 7 TA indicator(s) are bullish while HOOK’s TA Score has 5 bullish TA indicator(s).
DRTS (@Biotechnology) experienced а +2.97% price change this week, while HOOK (@Biotechnology) price change was -11.62% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.
DRTS is expected to report earnings on Mar 06, 2025.
HOOK is expected to report earnings on Nov 13, 2024.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
DRTS | HOOK | DRTS / HOOK | |
Capitalization | 219M | 25.7M | 852% |
EBITDA | -28.61M | -39.82M | 72% |
Gain YTD | 3.654 | -73.704 | -5% |
P/E Ratio | N/A | N/A | - |
Revenue | 0 | 50M | - |
Total Cash | 71M | 59.8M | 119% |
Total Debt | 12.6M | 2.83M | 446% |
DRTS | HOOK | |
---|---|---|
RSI ODDS (%) | 2 days ago76% | 2 days ago85% |
Stochastic ODDS (%) | 2 days ago65% | 2 days ago70% |
Momentum ODDS (%) | 2 days ago54% | 2 days ago90% |
MACD ODDS (%) | 2 days ago57% | 2 days ago79% |
TrendWeek ODDS (%) | 2 days ago55% | 2 days ago89% |
TrendMonth ODDS (%) | 2 days ago52% | 2 days ago90% |
Advances ODDS (%) | 2 days ago61% | 10 days ago73% |
Declines ODDS (%) | 15 days ago72% | 6 days ago90% |
BollingerBands ODDS (%) | 2 days ago69% | 2 days ago68% |
Aroon ODDS (%) | 2 days ago44% | 2 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTCWX | 13.63 | -0.01 | -0.07% |
Fidelity Advisor Asset Manager 20% C | |||
DPTAX | 33.18 | -0.08 | -0.24% |
BNY Mellon Tax Managed Growth C | |||
HESGX | 46.04 | -0.14 | -0.30% |
Horizon Defensive Core Investor | |||
FSYNX | 8.78 | -0.05 | -0.57% |
Fidelity Advisor Sustainable EM Eq M | |||
RPRCX | 8.47 | -0.11 | -1.28% |
Royce Premier Consult |
A.I.dvisor indicates that over the last year, DRTS has been loosely correlated with FRTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DRTS jumps, then FRTX could also see price increases.
Ticker / NAME | Correlation To DRTS | 1D Price Change % | ||
---|---|---|---|---|
DRTS | 100% | +0.65% | ||
FRTX - DRTS | 37% Loosely correlated | N/A | ||
ARDX - DRTS | 27% Poorly correlated | -13.54% | ||
HOOK - DRTS | 24% Poorly correlated | -1.84% | ||
COGT - DRTS | 24% Poorly correlated | -0.85% | ||
PSTX - DRTS | 24% Poorly correlated | -0.11% | ||
More |
A.I.dvisor indicates that over the last year, HOOK has been closely correlated with FRES. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if HOOK jumps, then FRES could also see price increases.
Ticker / NAME | Correlation To HOOK | 1D Price Change % | ||
---|---|---|---|---|
HOOK | 100% | -1.84% | ||
FRES - HOOK | 75% Closely correlated | -10.54% | ||
KZIA - HOOK | 66% Loosely correlated | +2.10% | ||
QURE - HOOK | 44% Loosely correlated | -5.40% | ||
MTVA - HOOK | 43% Loosely correlated | +1.75% | ||
MGTX - HOOK | 36% Loosely correlated | +1.91% | ||
More |